Showing 12,901 - 12,920 results of 224,509 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greatest decrease) OR (largest decrease)) ))', query time: 1.24s Refine Results
  1. 12901

    Image 1_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  2. 12902

    Table 1_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.docx by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  3. 12903

    Image 5_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  4. 12904

    Image 6_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  5. 12905

    Image 2_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  6. 12906

    Image_4_Social Deficits and Cerebellar Degeneration in Purkinje Cell Scn8a Knockout Mice.JPEG by Xiaofan Yang (767342)

    Published 2022
    “…At 9 months of age, Scn8a<sup>flox/flox</sup>, L7Cre<sup>+</sup> mice exhibited decreased cerebellar size and a reduced number of cerebellar Purkinje cells more profoundly, with evidence of additional neurodegeneration in the molecular layer and deep cerebellar nuclei. …”
  7. 12907

    Data_Sheet_1_CagA+Helicobacter pylori, Not CagA–Helicobacter pylori, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation.pdf by Xiujuan Xia (11929241)

    Published 2022
    “…CagA<sup>+</sup>H. pylori, not CagA<sup>–</sup>H. pylori, infection significantly increased aortic ROS production, decreased ACh-induced aortic relaxation, and enhanced early atherosclerosis formation, which were prevented with N-acetylcysteine treatment. …”
  8. 12908
  9. 12909
  10. 12910
  11. 12911
  12. 12912
  13. 12913
  14. 12914
  15. 12915
  16. 12916
  17. 12917

    DataSheet_1_IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.docx by Adela Navrátilová (11589532)

    Published 2021
    “…Background<p>Interleukin 40 (IL-40) is a newly identified B cell-associated cytokine implicated in humoral immune responses and B cell homeostasis. …”
  18. 12918

    DataSheet_1_Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.pdf by Haein Kim (4839594)

    Published 2023
    “…In the multivariable analysis, regdanvimab was significantly associated with a decreased risk for O<sub>2</sub> support (HR 0.677, 95% CI 0.561–0.816) and progression to severe disease (HR 0.489, 95% CI 0.337–0.709). …”
  19. 12919

    Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A<sub>1</sub> ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in the medial EC. by Shouping Wang (402959)

    Published 2013
    “…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A<sub>1</sub> AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A<sub>1</sub> ARs. …”
  20. 12920

    Image_3_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Critical Illness.tiff by Shirin Hasan (7894118)

    Published 2019
    “…There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”